Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium
Clinical trial NCT03671603 · COMPLETED
Trial details
- NCT number
- NCT03671603
- Sponsor
- GE Healthcare
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-11-05
- Primary completion
- 2021-06-07
- Enrollment
- 2755
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.